AltMountain

MPM Oncology Innovations Fund LP

Cambridge, MA · CIK 1719960
Status: no Form D since Feb 2020. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

MPM Oncology Innovations Fund LP is a venture capital fund based in Cambridge, Massachusetts. According to its most recent Form D, filed Feb 26, 2020, it has sold $98,879,004 of interests to 36 investors since its first sale in Jul 2018. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include MPM Oncology Innovations Fund GP LLC; Luke Evnin; Ansbert Gadicke.

Total raised
$98,879,004Cumulative sales reported on Form D
Investors
36
First sale
Jul 12, 2018
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
MPM Oncology Innovations Fund GP LLC; Luke Evnin; Ansbert Gadicke
Latest Form D
Feb 26, 2020

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​‌⁠

Raise history

$98,879,004Jun 29, 2018: $0 raisedJul 1, 2019: $52,650,002 raisedFeb 26, 2020: $98,879,004 raisedJun 2018Feb 2020
FiledFilingTotal raisedInvestorsSource
Feb 26, 2020Form D/A (amendment)$98,879,00436SEC.gov ↗
Jul 1, 2019Form D/A (amendment)$52,650,00231SEC.gov ↗
Jun 29, 2018Form D$00SEC.gov ↗

3 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jun 29, 2018. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about MPM Oncology Innovations Fund LP

What is the minimum investment for MPM Oncology Innovations Fund LP?

MPM Oncology Innovations Fund LP's latest Form D, filed Feb 26, 2020, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in MPM Oncology Innovations Fund LP?

MPM Oncology Innovations Fund LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has MPM Oncology Innovations Fund LP raised?

MPM Oncology Innovations Fund LP reports $98,879,004 sold from 36 investors on its Form D filed Feb 26, 2020. This is cumulative sales since the offering began, not current assets or performance.

Where is MPM Oncology Innovations Fund LP based?

MPM Oncology Innovations Fund LP is based in Cambridge, Massachusetts.

When did MPM Oncology Innovations Fund LP launch?

MPM Oncology Innovations Fund LP reports its first sale in Jul 2018.

Size compared with every venture capital fund

Raised more than 94% of the 533 venture capital funds based in Massachusetts, and more than 98% of all 14,877 that report sales.

More venture capital funds in Cambridge

Similar-size venture capital funds in Massachusetts

All venture capital funds in Massachusetts